Tufts Health Plan Has Updated Its Clinical Coverage Criteria Regarding Hepatitis C Drugs

Tufts Health Plan has updated its clinical coverage criteria regarding Hepatitis C drugs. This comes as a result of continual review of criteria in light of emerging research and new clinical guidance; consultation with external physicians; FDA and other government agency policies and standards adopted by national specialty organizations.


The new criteria removes previous restrictions for treating members with early stage liver disease. It applies to Commercial and Medicaid members.